Prolactin Levels by Age: What Your Results Mean at Every Decade of Life

What Is Prolactin and Why Does It Matter for Women?

Prolactin is a hormone made by the lactotroph cells of the anterior pituitary gland. Its most recognized job is stimulating breast milk production after delivery, but it also modulates the hypothalamic-pituitary-ovarian axis, meaning elevated levels can suppress GnRH, blunt LH and FSH surges, and disrupt ovulation. That makes prolactin one of the most clinically relevant pituitary hormones in women's reproductive health.

For women, an out-of-range prolactin is rarely just a lab number. It can explain irregular periods, infertility, galactorrhea (unexpected breast milk outside pregnancy), low libido, and even bone loss.

What Prolactin Actually Does Beyond Lactation

Prolactin has over 300 known biological actions, though most research in women focuses on its reproductive and metabolic effects. Receptors for prolactin exist in the ovary, uterus, breast, immune cells, and brain. When prolactin rises too high for too long, it suppresses the pulsatile GnRH that drives the menstrual cycle, producing a state called hypogonadotropic hypogonadism. This is the same hormonal picture seen in hypothalamic amenorrhea, which is why the two conditions are sometimes confused on initial workup.

How the Lab Measures It

Most clinical labs report serum prolactin using immunoassay. Results come back in ng/mL or mIU/L (to convert: 1 ng/mL ≈ 21.2 mIU/L). The standard reference interval for non-pregnant, non-lactating women is roughly 3 to 25 ng/mL, though lab-specific ranges vary slightly. A single elevated result is never diagnostic on its own: physical stress, a recent breast exam, vigorous exercise, sexual activity within 24 hours, and even poor sleep can temporarily raise prolactin.

The Optimal Prolactin Range: What "Normal" Actually Means

"Normal" on a lab report means within the reference interval for a mixed population sample. "Optimal" is a more useful question, and the answer depends on your life stage.

For most non-pregnant, non-lactating women, a prolactin below 15 ng/mL is associated with unimpeded ovulation and regular menstrual cycles. Values between 15 and 25 ng/mL sit in a gray zone: technically within range, but worth correlating with cycle regularity and symptoms. Any value above 25 ng/mL in a non-pregnant, non-lactating woman is considered hyperprolactinemia and needs further evaluation.

Why the Threshold Matters for Fertility

The relationship between prolactin and fertility is dose-dependent. Mildly elevated levels (25 to 50 ng/mL) may cause luteal phase defects or subtle ovulatory irregularities without full cycle disruption. Moderate elevation (50 to 100 ng/mL) commonly produces oligomenorrhea or amenorrhea. Values above 100 ng/mL raise suspicion for a pituitary prolactinoma, the most common pituitary tumor in women of reproductive age.

What the Endocrine Society Says

The 2011 Endocrine Society Clinical Practice Guideline on hyperprolactinemia defines hyperprolactinemia as a serum prolactin consistently above the upper limit of normal for the assay used, and recommends repeating the test under fasting, mid-morning conditions before any imaging or treatment is initiated. The guideline specifically notes that a single moderately elevated value should not trigger a pituitary MRI without confirmatory testing.

Prolactin by Decade: A Life-Stage Interpretation Guide

Prolactin does not stay static across your life. Here is how to read your result at each decade, accounting for the hormonal shifts that actually change the number.

Teens and Early 20s (Ages 13 to 24): Establishing a Baseline

Pubertal development includes a modest rise in basal prolactin as estrogen levels climb. By the mid-teens, prolactin settles into the adult female range of 3 to 25 ng/mL. In this age group, an elevated prolactin most commonly reflects one of four things: stress-related hypothalamic disruption, a medication side effect, a small microprolactinoma, or undiagnosed PCOS.

Irregular cycles in teenagers are common and often dismissed, but a prolactin check is worthwhile when periods are absent for more than 90 days outside pregnancy or when galactorrhea is present. The American College of Obstetricians and Gynecologists (ACOG) recommends treating the menstrual cycle as a vital sign starting in early adolescence, which means lab evaluation of amenorrhea is appropriate at any age.

PCOS Overlap in Young Women

Roughly 10 to 30% of women with PCOS have mildly elevated prolactin, likely because the elevated estrogen environment stimulates lactotroph cells. In a young woman with irregular cycles, acne, and androgen excess, a prolactin in the 25 to 40 ng/mL range may reflect PCOS physiology rather than a pituitary tumor, but the two can coexist and both warrant investigation.

20s and 30s: Reproductive Years and Fertility

These are the decades when prolactin results most directly affect family planning decisions. In women trying to conceive, a prolactin above 25 ng/mL can impair natural conception by blunting the LH surge needed for ovulation. In IVF cycles, elevated baseline prolactin is associated with lower clinical pregnancy rates.

The good news: hyperprolactinemia from a microprolactinoma (a pituitary tumor under 10 mm) is highly treatable with dopamine agonists such as cabergoline, and ovulatory function typically restores within weeks of prolactin normalization.

Menstrual Cycle Variation

Prolactin fluctuates across the menstrual cycle. It peaks briefly around ovulation, driven by the mid-cycle estrogen surge, then falls in the luteal phase. Values drawn in the follicular phase (days 2 to 5) are most comparable to population reference ranges. A result drawn at ovulation or in the mid-luteal phase may appear mildly elevated and not reflect a true pathological state.

Oral Contraceptives and Prolactin

Combined oral contraceptives contain ethinyl estradiol, which mildly stimulates pituitary lactotroph cells. Most women on the pill show prolactin values in the upper-normal range, typically 15 to 25 ng/mL. A value above 40 ng/mL on OCP use warrants further assessment rather than attribution to the pill alone.

30s and 40s: Perimenopause Begins Earlier Than You Think

Perimenopause can start as early as the late 30s for some women, though the average onset is the mid-to-late 40s. During early perimenopause, fluctuating estrogen levels create variable prolactin signals. The Menopause Society (formerly NAMS) notes that hormonal variability in perimenopause makes single-point lab measurements less reliable, and serial testing gives a clearer picture.

In this decade, a new finding of elevated prolactin should still trigger full evaluation. Do not assume that menstrual irregularity is "just perimenopause" without ruling out hyperprolactinemia, which is entirely treatable and a common missed diagnosis in women in their 40s.

Antidepressants, Antipsychotics, and Other Prolactin-Raising Medications

Several medications commonly prescribed to women in their 30s and 40s raise prolactin by blocking dopamine, the primary inhibitor of prolactin secretion. These include:

• SSRIs (particularly paroxetine and fluoxetine, though the effect is modest)
• Antipsychotics, especially risperidone, haloperidol, and metoclopramide
• Domperidone (used for nausea and off-label to boost milk supply)
• Verapamil (a calcium channel blocker used for blood pressure and migraine)
• H2 blockers such as cimetidine (less common now)

Drug-induced hyperprolactinemia is the most common cause of elevated prolactin in clinical practice. Medication review is always the first step before ordering pituitary imaging.

40s and 50s: Perimenopause and the Transition to Menopause

As ovarian estrogen production declines through perimenopause and into menopause, basal prolactin tends to fall modestly. Post-menopausal women typically have prolactin values of 2 to 15 ng/mL, reflecting lower tonic estrogen stimulation of lactotroph cells.

This does not mean elevated prolactin in a post-menopausal woman is benign. A value above 25 ng/mL after menopause still warrants pituitary MRI, because the pre-test probability of a clinically significant lesion is actually higher at this stage: physiological causes (pregnancy, breastfeeding) have been ruled out by definition.

Hormone Therapy and Prolactin

Menopausal hormone therapy (MHT) containing estrogen can mildly raise prolactin, particularly oral estradiol, which delivers higher hepatic estrogen exposure than transdermal routes. Transdermal estradiol patches or gels produce a smaller prolactin effect. If you are on MHT and your prolactin is mildly elevated, the formulation and route matter when interpreting the result.

The Endocrine Society guideline recommends considering the estrogen exposure from MHT when interpreting prolactin in post-menopausal women, and advises repeat testing off MHT for 4 to 6 weeks if the value is only mildly elevated and no symptoms are present.

60s and Beyond: Post-Menopause

After menopause, prolactin settles at its lowest adult levels. Values above 25 ng/mL in a woman in her 60s or 70s should not be attributed to age-related changes. Common causes at this stage include macroprolactinoma, hypothyroidism (elevated TRH stimulates prolactin release), renal failure, and medication effect.

The WomanRx Prolactin Decade Framework organizes clinical interpretation as follows:

| Life Stage | Expected Range | Top Cause if Elevated | First Step | |---|---|---|---| | Teens / Early 20s | 3 to 25 ng/mL | PCOS, stress, medication | Repeat fasting AM level | | Reproductive 20s, 30s | 3 to 25 ng/mL | Microprolactinoma, OCP | Medication review, MRI if >50 ng/mL | | Perimenopause 40s, 50s | 3 to 25 ng/mL | Medication, macroprolactin | Route/MHT review, serial testing | | Post-menopause 60s+ | 2 to 15 ng/mL | Macroprolactinoma, hypothyroidism | TSH, pituitary MRI |

Conditions That Raise Prolactin in Women: A Sex-Specific List

Women are disproportionately affected by hyperprolactinemia. Prolactinomas are 2 to 5 times more common in women than men, and women present earlier because their symptoms, cycle disruption and galactorrhea, are more immediately noticeable.

Beyond prolactinoma, conditions particularly relevant to women include:

Hypothyroidism. Primary hypothyroidism elevates TRH, which directly stimulates prolactin release. Always check TSH alongside prolactin. Subclinical hypothyroidism can produce prolactin values in the 30 to 50 ng/mL range that fully normalize once levothyroxine brings TSH into range.

PCOS. As noted above, mildly elevated prolactin in PCOS is common. The Rotterdam criteria for PCOS diagnosis require ruling out hyperprolactinemia as a separate diagnosis before attributing cycle irregularity to PCOS alone.

Endometriosis. Emerging data suggest prolactin may be elevated in peritoneal fluid of women with endometriosis, though serum prolactin is not used as a diagnostic marker.

Macroprolactinemia. Up to 25% of women with apparent hyperprolactinemia have macroprolactin, a large biologically inactive form of prolactin that clears slowly from circulation and produces elevated serum values without symptoms. A polyethylene glycol (PEG) precipitation assay distinguishes true monomeric prolactin from macroprolactin and prevents unnecessary MRI and treatment.

Pregnancy and Lactation: Expected Values and Clinical Meaning

Pregnancy is the most dramatic example of physiological hyperprolactinemia in women.

During pregnancy, estrogen primes the pituitary lactotrophs, causing a 10-fold expansion of pituitary volume and prolactin levels that climb from 25 ng/mL in the first trimester to 200 to 400 ng/mL by the third trimester. These values are entirely normal in pregnancy and do not require further evaluation.

After delivery, prolactin falls over days unless breastfeeding is established. With exclusive breastfeeding, each nursing episode produces a prolactin spike that maintains milk supply. Basal prolactin during active lactation runs 100 to 300 ng/mL in the first weeks postpartum, then gradually declines over months as feeding frequency decreases.

Prolactinoma in Pregnancy: A Specific Risk

Women with known prolactinomas who become pregnant face a specific management question. Microprolactinomas (<10 mm) rarely grow during pregnancy. Macroprolactinomas (>10 mm) carry a 20 to 30% risk of symptomatic enlargement during pregnancy, potentially causing visual field defects from chiasm compression. Dopamine agonist therapy is typically discontinued at confirmed pregnancy for microprolactinoma patients, and continued or restarted for macroprolactinoma patients with close monitoring.

Cabergoline is the preferred dopamine agonist for women with prolactinoma who are planning pregnancy. Published data on more than 800 cabergoline-exposed pregnancies show no significant increase in fetal malformation or pregnancy loss, though the dataset is smaller than for bromocriptine. ASRM and the Endocrine Society both advise using a barrier method until prolactin normalizes and then discontinuing cabergoline once pregnancy is confirmed for microprolactinoma patients.

Postpartum Prolactin and the Return of Your Cycle

Elevated prolactin during breastfeeding suppresses ovulation, which is the physiological basis for lactational amenorrhea. This is not a reliable contraception method beyond six months or once feeds drop below 6 to 8 per day. As prolactin falls post-weaning, the first ovulation typically precedes the first period by about two weeks, meaning you can conceive before your cycle returns.

Who Should Get a Prolactin Test?

A prolactin measurement is appropriate if you have any of the following:

• Irregular or absent periods not explained by pregnancy or another confirmed diagnosis
• Galactorrhea (breast milk outside pregnancy or breastfeeding)
• Unexplained infertility, particularly with evidence of ovulatory dysfunction
• Newly diagnosed PCOS (to exclude concurrent hyperprolactinemia per Rotterdam criteria)
• Headaches with visual changes (possible pituitary mass)
• Low libido with no other explanation, particularly in pre-menopausal women
• Starting a medication known to raise prolactin, as a baseline measure

Who Does Not Need Routine Prolactin Testing?

A post-menopausal woman with no symptoms does not need routine prolactin screening. Women on stable MHT whose prior prolactin was normal do not need annual re-testing unless symptoms develop. ACOG does not recommend prolactin as part of a routine annual lab panel in asymptomatic women.

How to Prepare for an Accurate Prolactin Test

Test preparation matters more for prolactin than for most routine labs. To get a result you can actually use:

• Draw blood mid-morning (8 to 11 AM), fasting or at least 2 hours after eating
• Avoid breast stimulation, vigorous exercise, and sexual activity for 24 hours before the draw
• Avoid a breast exam immediately before the blood draw
• If you are taking a medication known to raise prolactin, discuss with your clinician whether a medication-off window is feasible before attributing the elevation to pathology
• If your first result is elevated, ask for a repeat under the same conditions before proceeding to imaging

Stress from venipuncture itself can acutely raise prolactin, which is why some endocrinologists place an IV catheter and wait 20 to 30 minutes before drawing, particularly when moderate elevations need confirmation.

When Your Prolactin Is Elevated: What Happens Next?

A confirmed prolactin above 25 ng/mL in a non-pregnant, non-lactating woman triggers a stepwise workup.

Step 1: Review all medications. Discontinue or substitute the offending agent if possible and recheck prolactin in 3 to 4 days.

Step 2: Check TSH. Hypothyroidism is a treatable cause that, when corrected, normalizes prolactin without further intervention.

Step 3: If prolactin remains elevated above 25 ng/mL with no medication or thyroid explanation, the Endocrine Society guideline recommends pituitary MRI with gadolinium contrast. The only exception is prolactin above 250 ng/mL, which is essentially diagnostic of macroprolactinoma and imaging can precede other steps.

Step 4: If macroprolactin is suspected (elevated prolactin but no symptoms), request a PEG precipitation assay before committing to MRI or treatment.

Step 5: For confirmed prolactinoma, cabergoline is first-line therapy. It normalizes prolactin in approximately 80 to 90% of patients with microprolactinoma and restores ovulatory cycles in most women within 4 to 8 weeks.

The Evidence Gap: What We Do Not Know Yet

Women have been central to prolactin research because of lactation, but several gaps remain.

Prolactin reference ranges were largely established in mixed-sex or small cohorts without adequate stratification by menstrual cycle phase, ethnicity, or body composition. Women with higher BMI tend to have modestly lower prolactin, which means a standard cutoff of 25 ng/mL may need adjustment depending on metabolic context. Whether prolactin has independent cardiovascular or metabolic effects in women across the menopause transition is an active research question with no definitive guideline yet.

The long-term safety of cabergoline beyond 10 years of use in women with prolactinoma has not been studied in randomized controlled trials. Most outcome data come from observational registries. This is an honest limitation of current evidence, and the decision to continue, taper, or discontinue cabergoline after 2 years of normal prolactin should be individualized.